PHASTAR announced the appointment of Cary Morrill as Chief People Officer.
Science 37 announced Elisa Cascade has joined the company and its senior executive team as Chief Product Officer. Additionally, Chris Ceppi has been appointed to serve as Chief Technology Officer. Science 37 also announced the appointment of Emily Rollins to its Board of Directors. Ms. Rollins will serve as the chairperson for the Audit Committee.
Certara, Inc. announced the appointment of Drayton T. Virkler to the newly created position of Chief Commercial Officer.
Calyx announced that two of the world’s Top 5 pharmaceutical companies have chosen to continue using the Calyx Regulatory Information Management system.
Certara, Inc. announced that its Simcyp COVID-19 Vaccine Model has won an R&D 100 Award.
CluePoints announced it has been shortlisted for Clinical Advance of the Year - COVID-19 Pandemic Special Recognition Award at the Scrip Awards, as well as two Citeline Awards—´Best Sponsor-facing Technology Initiative´ and ´Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities’.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.